J Bacteriol Virol.  2011 Dec;41(4):237-244. 10.4167/jbv.2011.41.4.237.

Exploitation of Culture Medium for Mycobacterium tuberculosis

• Kim H
• Ryoo S

• KMID: 2168651
• DOI: http://doi.org/10.4167/jbv.2011.41.4.237

Abstract

The culture media for Mycobacterium tuberculosis (MTB) were contrived from both egg-based and agar based ingredients. In 1903, Dorset introduced the first egg-based medium. It was followed by the invention of Lowenstein-Jensen and Ogawa media that contain whole eggs as nutrient and malachite green to inhibit the growth of contaminants. These media have been used worldwide for their usefulness and inexpensiveness. However they have a fundamental disadvantage that the cultivation time for mycobacterial growth takes more than 4 weeks. In 1947, Dubos introduced the first agar medium and followed by the invention of the 7H10 by Middlebrook and Cohn. A powder base of these media contains agar, combination of seven salts, L-glutamic acid, pyridoxine, biotin, and malachite green. This requires the addition of the oleic acid, albumin, dextrose, and catalase (OADC) growth supplement. BACTEC MGIT960 has recently been introduced for rapid cultivation of MTB, which is fully automated liquid culture system with modified 7H9 broth. Agar-based medium developed by Middlebrook has a number of advantages over egg-based medium. One of them is transparency, which enables earlier detection of growing colonies. The major disadvantages of agar media are the high cost of OADC and the need for a CO2 incubator. In conclusion, there is a need for a new agar medium, which can be produced at a lower cost and earlier growth detection. In this review, we introduced the growth promoting factors which can be used as an alternative new growth supplement, cAMP and resuscitation-promoting factor (Rpf). These factors may abrogate a lag in adaption of the bacilli in culture media.

Keyword

Mycobacterium tuberculosis; Lowenstein-Jensen; Ogawa; 7H10; Growth promoting factor

MeSH Terms

Agar
Biotin
Catalase
Culture Media
Eggs
Glucose
Glutamic Acid
Incubators
Inventions
Mycobacterium
Mycobacterium tuberculosis
Oleic Acid
Ovum
Pyridoxine
Rosaniline Dyes
Salts
Agar
Biotin
Catalase
Culture Media
Glucose
Glutamic Acid
Oleic Acid
Pyridoxine
Rosaniline Dyes
Salts

Reference

1). Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010; 50:S201–7.

2). Korea centers for disease control & prevention. Analysis of notified tuberculosis cases in Korea, 2009. Public health weekly report, KCDC. 2010; 14:621–7.

3). Gradmann C. Robert Koch and the pressures of scientific research: tuberculosis and tuberculin. Med Hist. 2001; 45:1–32.

4). Dorset M. The use of eggs as a medium for the cultivation of Bacillus tuberculosis. Am Med. 1902; 3:555–6.

5). Lepper AW, Newton-Tabrett DA, Corner LA, Carpenter MT, Scanlan WA, Williams OJ, et al. The use of bovine PPD tuberculin the single caudal fold test to detect tuberculosis in beef cattle. Aust Vet J. 1977; 53:208–13.

6). Christensen WB, Leach RE. Egg agar medium for the primary isolation of Mycobacterium tuberculosis. Health Lab Sci. 1966; 3:39–43.

7). Saito H. Laboratory media for the cultivation of tubercule bacillus. Kekkaku. 1998; 73:329–37.

8). Parish T, Stoker NG. Mycobacterium tuberculosis protocols. New Jersey: Humana Press;2001.

9). Hirsch JG. Studies on egg-yolk growth factors for tubercle bacilli. Am Rev Tuberc. 1954; 70:977–88.

10). Isabel NDK, Kim SJ, Frieden T, Laszlo A, Luelmo F, Norval P-Y, et al. Laboratory services in Tuberculosis control culture part III: For the global Tuberculosis program. Geneva: World Health Organization;(WHO/TB/98.258). 1998.

11). Piddington DL, Kashkouli A, Buchmeier NA. Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg⁽²⁺⁾ levels. Infect Immun. 2000; 68:4518–22.

12). Keating LA, Wheeler PR, Mansoor H, Inwald JK, Dale J, Hewinson RG, et al. The pyruvate requirement of some members of the Mycobacterium tuberculosis complex is due to an inactive pyruvate kinase: implications for in vivo growth. Mol Microbiol. 2005; 56:163–74.

13). Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981; 14:686–91.

14). Dubos RJ, Davis BD. Factors affecting the growth of tubercle bacilli in liquid media. J Exp Med. 1946; 83:409–23.

15). Dubos RJ. The effect of lipids and serum albumin on bacterial growth. J Exp Med. 1947; 85:9–22.

16). Dubos RJ, Middlebrook G. The effect of wetting agents on the growth of tubercle bacilli. J Exp Med. 1948; 88:81–8.

17). Fenner F, Dubos RJ. Production of BCG vaccine in a liquid medium containing tween 80 and a soluble fraction of heated human serum: II. Antigenicity of the Culture after Various Periods of Storage. J Exp Med. 1950; 91:269–84.

18). Moberg C. Rene Dubos. Friend of the good earth. Washington D.C.: ASM press;2005.

19). Dubos RJ, Middlebrook G. Media for tubercle bacilli. Am Rev Tuberc. 1947; 56:334–45.

20). Middlebrook G, Cohn ML. Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health. 1958; 48:844–53.

21). Middlebrook G, Cohn ML, Schaefer WB. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc. 1954; 70:852–72.

22). Cohn ML, Waggoner RF, McClatchy JK. The 7H11 medium for the cultivation of mycobacteria. Am Rev Respir Dis. 1968; 98:295–6.

23). Lin SY, Desmond E, Bonato D, Gross W, Siddiqi S. Multicenter evaluation of bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol. 2009; 47:3630–4.

24). Welch DF, Guruswamy AP, Sides SJ, Shaw CH, Gilchrist MJ. Timely culture for mycobacteria which utilizes a microcolony method. J Clin Microbiol. 1993; 31:2178–84.

25). Besra GS, Chatterjee D. Lipids and carbohydrates of Mycobacterium tuberculosis. Washington D.C.: ASM press;1994.

26). Chauhan A, Madiraju MV, Fol M, Lofton H, Maloney E, Reynolds R, et al. Mycobacterium tuberculosis cells growing in macrophages are filamentous and deficient in FtsZ rings. J Bacteriol. 2006; 188:1856–65.

27). Bashyam MD, Kaushal D, Dasgupta SK, Tyagi AK. A study of mycobacterial transcriptional apparatus: identification of novel features in promoter elements. J Bacteriol. 1996; 178:4847–53.

28). Winder FG. Mole of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria. New York.: Academic Press;1982.

29). Gazdik MA, McDonough KA. Identification of cyclic AMP-regulated genes in Mycobacterium tuberculosis complex bacteria under low-oxygen conditions. J Bacteriol. 2005; 187:2681–92.

30). Botsford JL. Cyclic nucleotides in procaryotes. Microbiol Rev. 1981; 45:620–42.

31). Rickman L, Scott C, Hunt DM, Hutchinson T, Menéndez MC, Whalan R, et al. A member of the cAMP receptor protein family of transcription regulators in Mycobacterium tuberculosis is required for virulence in mice and controls transcription of the rpfA gene coding for a resuscitation promoting factor. Mol Microbiol. 2005; 56:1274–86.

32). Bai G, McCue LA, McDonough KA. Characterization of Mycobacterium tuberculosis Rv3676 (CRPMt), a cyclic AMP receptor protein-like DNA binding protein. J Bacteriol. 2005; 187:7795–804.

33). Barba J, Alvarez AH, Flores-Valdez MA. Modulation of cAMP metabolism in Mycobacterium tuberculosis and its effect on host infection. Tuberculosis. 2010; 90:208–12.

34). Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol. 2001; 55:139–63.

35). Hu YM, Butcher PD, Sole K, Mitchison DA, Coates AR. Protein synthesis is shut down in dormant Mycobacterium tuberculosis and is reversed by oxygen or heat shock. FEMS Microbiol Lett. 1998; 158:139–45.

36). Kaprelyants AS, Gottschal JC, Kell DB. Dormancy in nonsporulating bacteria. FEMS Microbiol Rev. 1993; 10:271–85.

37). Kaprelyants AS, Mukamolova GV, Kell DB. Estimation of dormant Micrococcus luteus cells by penicillin lysis and by resuscitation in cell-free spent culture medium at high dilution. FEMS Microbiol Lett. 1994; 115:347–52.

38). Mukamolova GV, Kaprelyants AS, Young DI, Young M, Kell DB. A bacterial cytokine. Proc Natl Acad Sci U S A. 1998; 95:8916–21.

39). Shleeva MO, Bagramyan K, Telkov MV, Mukamolova GV, Young M, Kell DB, et al. Formation and resuscitation of “non-culturable” cells of Rhodococcus rhodochrous and Mycobacterium tuberculosis in prolonged stationary phase. Microbiology. 2002; 148:1581–91.

40). Wu X, Yang Y, Han Y, Zhang J, Liang Y, Li H, et al. Effect of recombinant Rv1009 protein on promoting the growth of Mycobacterium tuberculosis. J Appl Microbiol. 2008; 105:1121–7.

41). Mukamolova GV, Murzin AG, Salina EG, Demina GR, Kell DB, Kaprelyarnts AS, et al. Muralytic acitivity of Micrococcus luteus Rpf and its relationship to physiological activity in promoting bacterial growth and resuscitation. Mol Microbiol. 2006; 59:84–98.

42). Keep NH, Ward JM, Cohen-Gonsaud M, Henderson B. Wake up! Peptidogylcan lysis and bacterial non-growth states. Trends Microbiol. 2006; 14:271–6.